REKAMBYS

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, United Kingdom

Active ingredients

The drug REKAMBYS contains one active pharmaceutical ingredient (API):

1 Rilpivirine
UNII FI96A8X663 - RILPIVIRINE

Rilpivirine is a diarylpyrimidine NNRTI of HIV-1. Rilpivirine activity is mediated by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Rilpivirine does not inhibit the human cellular DNA polymerases α, β and γ.

Read about Rilpivirine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
REKAMBYS Prolonged-release suspension for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AG05 Rilpivirine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1835535, 1835546
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 093653
Country: FR Base de données publique des médicaments Identifier(s): 60150638
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9040
Country: IT Agenzia del Farmaco Identifier(s): 049280011, 049280023
Country: JP 医薬品医療機器総合機構 Identifier(s): 6250409A1022, 6250409A2029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1091686, 1091687
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100445800, 100445816

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.